Oral tolerance in disease
Open Access
- 1 January 1999
- Vol. 44 (1) , 137-142
- https://doi.org/10.1136/gut.44.1.137
Abstract
The large surface area of the gastrointestinal tract is covered by a single layer of columnar epithelium which allows efficient absorption of nutrients, but also offers a potential portal of entry for microbial pathogens. Thus, a highly structured immune network, the GALT has evolved as an integral part of the intestine to provide protection against pathogenetic microorganisms.1 However, the intestinal immune system is faced with the dilemma of discriminating between antigens with no pathogenetic potential (dietary proteins and commensal organisms) and antigens associated with potentially harmful microbes. It has long been recognised that the encounter of dietary antigens by the immune system normally leads to antigen specific tolerance.2 This phenomenon has been termed oral tolerance and can be induced by most soluble antigens.3 , 4 The consequences of the apparent breakdown of oral tolerance to dietary antigens are exemplified by diseases such as gluten sensitive enteropathy (coeliac disease) and other food sensitive enteropathies.4 The intestinal immune system must also maintain stringent control over responses to its resident bacterial flora. These organisms are essential for normal intestinal function, yet they constitute a potential challenge to the integrity of the host. Recent evidence suggests that the breakdown of intestinal immunoregulation of responses to endogenous flora may be the underlying cause of inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease.5-8 Understanding the mechanisms responsible for oral tolerance may lead to new treatment strategies for such conditions. In addition, antigen feeding may provide a potential immunotherapy for a number of systemic inflammatory disorders.Keywords
This publication has 98 references indexed in Scilit:
- Myelin Basic Protein–specific T Helper 2 (Th2) Cells Cause Experimental Autoimmune Encephalomyelitis in Immunodeficient Hosts Rather than Protect Them from the DiseaseThe Journal of Experimental Medicine, 1997
- Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammationImmunology Today, 1997
- Mechanisms of Oral ToleranceCritical Reviews in Immunology, 1997
- Intraocular Inflammatory Disease (Uveitis) and the Use of Oral Tolerance.Annals of the New York Academy of Sciences, 1996
- CD8 T-Cells Are Not Essential for the Induction of “Low-Dose” Oral ToleranceClinical Immunology and Immunopathology, 1996
- Regulatory Activity of Endogenous and Exogenous Transforming Growth Factor β in Experimental Intestinal ImmunopathologyGrowth Factors, 1996
- Suppression of the Immune Response by Nasal ImmunizationClinical Immunology and Immunopathology, 1994
- Suppression of Collagen Induced Arthritis by Oral Administration of Type II Collagen: Changes in Immune and Arthritic Responses Mediated by Active Peripheral SuppressionAutoimmunity, 1993
- Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptideCellular Immunology, 1992
- Could specific oral tolerance be a therapy for autoimmune disease?Immunology Today, 1990